Company Analysis

Phio Pharmaceuticals Corp. (PHIO)

Nasdaq: PHIO · Pharmaceutical Preparations · King Of Prussia, PA · filing with the SEC since 2011
Grade4.0
◀ Past 1.3● Present 4.6▶ Future 5.2
4 est.

Who runs Phio Pharmaceuticals Corp.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Bitterman Robert J
Chairman, Pres. & CEO. First filing Mar 2013, latest Nov 10, 2026, 20 filings in all.
Officers reporting now
2
of 8 people with a filing in the last fifteen months
Directors reporting now
6
17 people on the record since 2013
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Bitterman Robert JChairman, Pres. & CEOMar 2013Nov 10, 2026none
Carson Lisa CabottChief Financial OfficerJun 2025Sep 29, 2026none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Deming David HdirectorMar 2025Nov 12, 2026none
Plott Ronald TodddirectorJul 2026Nov 10, 2026none
Bradford Patricia AdirectorApr 2022Sep 25, 2026none
Freeman Jonathan EdirectorJun 2017Feb 6, 2026none
Lockshin CurtisdirectorApr 2013Feb 6, 2026none
Ferrara Robert LdirectorNov 2019Sep 15, 2025none
Earlier names on the record9, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PHIO · research, not advice